Clinical efficacy of a dentifrice and oral rinse containing sanguinaria extract and zinc chloride during 6 months of use.
The efficacy of combined use of toothpaste and oral rinse containing sanguinaria extract and zinc chloride was compared to placebo products in a 6-month clinical trial. Sixty subjects with moderate levels of plaque and gingivitis were randomly assigned to active and placebo groups. Noninvasive measures of plaque and gingivitis were assessed at baseline and at 2, 6, 8, 14, 20, and 28 weeks. Bleeding on probing was measured at baseline and 6, 14, and 28 weeks. Active group scores were significantly lower (P less than .0001) than placebo scores at each post-baseline time point for all indices, with the exception of plaque at 2 weeks. The 28 week active group scores were 21% lower than the placebo group for plaque, 25% lower for gingivitis, and 43% lower for bleeding on probing. No dental staining or taste alteration was reported in the active group. Three of 30 active group subjects exhibited minor soft tissue irritations that resolved spontaneously without discontinuation of product use. Results indicate that the test products showed good levels of safety and efficacy when administered in a combined use regimen for 6 months.
Fairleigh-Dickinson University, Oral Health Research Center, Hackensack, NJ.
D S
DS
Harper
L J
LJ
Mueller
J B
JB
Fine
J
J
Gordon
L L
LL
Laster
D000328:Adult; D000470:Alkaloids / Q000627:therapeutic use*; D000704:Analysis of Variance; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D053119:Benzophenanthridines; D002712:Chlorides / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003773:Dental Plaque / Q000517:prevention & control*; D003774:Dental Plaque Index; D003802:Dentifrices / Q000627:therapeutic use*; D004311:Double-Blind Method; D005260:Female; D005891:Gingivitis / Q000517:prevention & control*; D006801:Humans; D007546:Isoquinolines; D008297:Male; D009067:Mouthwashes / Q000627:therapeutic use*; D010512:Periodontal Index; D010919:Placebos; D011897:Random Allocation; D015032:Zinc / Q000627:therapeutic use*; D017967:Zinc Compounds
D000470:Alkaloids; D000890:Anti-Infective Agents; D053119:Benzophenanthridines; D002712:Chlorides; D003802:Dentifrices; D007546:Isoquinolines; D009067:Mouthwashes; D010919:Placebos; D017967:Zinc Compounds; C016837:zinc chloride; C005705:sanguinarine; D015032:Zinc